This startup develops clip-on devices that non-invasively measure hemoglobin levels, providing a faster and more accessible alternative to blood draws for anemia diagnosis. Their technology aims to reduce the cost and complexity associated with traditional anemia testing for both consumers and medical professionals.
Funding
$19.2K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Diagnosing anemia currently requires invasive blood draws, which are slow, costly, generate waste, and necessitate specialized staff and equipment. This creates barriers to widespread and frequent anemia screening, particularly in resource-limited settings and for individuals seeking convenient at-home testing.
Solution
SanguisAI is developing a non-invasive solution for instantaneous and inexpensive hemoglobin measurement using a clip-on device, aiming to diagnose anemia without the need for blood draws. The technology leverages optical sensors and AI algorithms to estimate hemoglobin levels from a smartphone, providing a faster and more accessible alternative for both consumers and medical professionals. By eliminating the need for specialized equipment and trained personnel, SanguisAI seeks to reduce the cost and complexity associated with traditional anemia testing, enabling more frequent and convenient monitoring of hemoglobin levels.
Target Audience
The primary target audience includes consumers seeking convenient at-home anemia screening, as well as medical professionals looking for a faster, less invasive, and more cost-effective diagnostic tool.
Features
- Non-invasive hemoglobin measurement using a clip-on device
- Smartphone-based diagnosis of anemia
- Instantaneous results without the need for laboratory processing
- Cost-effective solution eliminating the need for specialized staff and equipment
- Suitable for both consumers and professional medical service providers